DK0667920T3
(da)
*
|
1992-10-29 |
2003-04-14 |
Univ Jefferson |
Fremgangsmåder til påvisning af prostatacancermetastase
|
US5674682A
(en)
*
|
1992-10-29 |
1997-10-07 |
Thomas Jefferson University |
Nucleic acid primers for detecting micrometastasis of prostate cancer
|
US6103237A
(en)
*
|
1993-07-22 |
2000-08-15 |
Hybritech Incorporated |
Stable variant hK2 polypeptide
|
WO1995028498A1
(en)
*
|
1994-04-15 |
1995-10-26 |
The Trustees Of Columbia University In The City Of New York |
Method for molecular staging of prostate cancer
|
EP0804593A1
(en)
*
|
1994-05-10 |
1997-11-05 |
Mayo Foundation For Medical Education And Research |
Recombinant hk2 polypeptide
|
US5866679A
(en)
*
|
1994-06-28 |
1999-02-02 |
Merck & Co., Inc. |
Peptides
|
US6143864A
(en)
*
|
1994-06-28 |
2000-11-07 |
Merck & Co., Inc. |
Peptides
|
US5599686A
(en)
*
|
1994-06-28 |
1997-02-04 |
Merck & Co., Inc. |
Peptides
|
WO1996021042A2
(en)
*
|
1995-01-04 |
1996-07-11 |
Trustees Of Boston University |
Primers for the pcr amplification of metastatic sequences
|
AUPN274295A0
(en)
*
|
1995-05-02 |
1995-05-25 |
Garvan Institute Of Medical Research |
GDU, a novel signalling protein
|
CA2262403C
(en)
*
|
1995-07-31 |
2011-09-20 |
Urocor, Inc. |
Biomarkers and targets for diagnosis, prognosis and management of prostate disease
|
US6218529B1
(en)
|
1995-07-31 |
2001-04-17 |
Urocor, Inc. |
Biomarkers and targets for diagnosis, prognosis and management of prostate, breast and bladder cancer
|
US7785842B2
(en)
*
|
1996-03-26 |
2010-08-31 |
Oncomedx, Inc. |
Comparative analysis of extracellular RNA species
|
US8043835B1
(en)
|
1996-03-26 |
2011-10-25 |
Oncomedx, Inc. |
Methods for detecting and monitoring cancer using extracellular RNA
|
US6759217B2
(en)
*
|
1996-03-26 |
2004-07-06 |
Oncomedx, Inc. |
Method enabling use of extracellular RNA extracted from plasma or serum to detect, monitor or evaluate cancer
|
WO1997035589A1
(en)
*
|
1996-03-26 |
1997-10-02 |
Kopreski Michael S |
Method enabling use of extracellular rna extracted from plasma or serum to detect, monitor or evaluate cancer
|
US5861248A
(en)
*
|
1996-03-29 |
1999-01-19 |
Urocor, Inc. |
Biomarkers for detection of prostate cancer
|
EP0904397A4
(en)
*
|
1996-04-16 |
2003-01-29 |
Smithkline Beecham Corp |
METHOD FOR DETECTION OF THE PROSTATE SPECIFIC ANTIGEN USED FOR MONITORING AND DIAGNOSING PROSTATE CANCER
|
US5925519A
(en)
*
|
1996-06-03 |
1999-07-20 |
The Regents Of The University Of California |
Genetic alterations associated with prostate cancer
|
CN1238013A
(zh)
*
|
1996-11-14 |
1999-12-08 |
梅奥医学教育及研究基金会 |
转移性前列腺癌的检测方法
|
US6479263B1
(en)
|
1996-11-14 |
2002-11-12 |
Baylor College Of Medicine |
Method for detection of micrometastatic prostate cancer
|
EP0960214A4
(en)
*
|
1996-12-06 |
2004-08-04 |
Urocor Inc |
PATHOLOGICAL DIAGNOSIS USING RNA MESSENGER PROFILES
|
WO1998040513A1
(en)
*
|
1997-03-11 |
1998-09-17 |
Ferrari Anna C |
Method of detecting prostate cancer metastasis
|
US8440396B2
(en)
*
|
1997-03-14 |
2013-05-14 |
Oncomedx, Inc. |
Method enabling use of extracellular RNA extracted from plasma or serum to detect, monitor or evaluate cancer
|
US20070009934A1
(en)
*
|
1997-03-14 |
2007-01-11 |
Kopreski Michael S |
Method enabling use of extracellular RNA extracted from plasma or serum to detect, monitor or evaluate cancer
|
US6190857B1
(en)
*
|
1997-03-24 |
2001-02-20 |
Urocor, Inc. |
Diagnosis of disease state using MRNA profiles in peripheral leukocytes
|
US7332270B1
(en)
|
1997-03-24 |
2008-02-19 |
Urocor, Inc. |
Diagnosis of disease state using mRNA profiles in peripheral leukocytes
|
ATE404676T1
(de)
*
|
1997-04-30 |
2008-08-15 |
Hybritech Inc |
Prostat-spezifisches-antigenformen und verfahren zu ihrer bestimmung
|
US7659073B2
(en)
|
1997-04-30 |
2010-02-09 |
Hybritech Incorporated |
Forms of prostate specific antigens and methods for their detection
|
NO972006D0
(no)
*
|
1997-04-30 |
1997-04-30 |
Forskningsparken I Aas As |
Ny metode for diagnose av sykdommer
|
US7288636B2
(en)
|
1997-04-30 |
2007-10-30 |
Hybritech Incorporated |
Forms of prostate specific antigens and methods for their detection
|
AU8259798A
(en)
|
1997-06-20 |
1999-01-04 |
George G Klee |
Method for detection of breast cancer
|
DE19736691A1
(de)
*
|
1997-08-22 |
1999-02-25 |
Michael Prof Dr Med Giesing |
Verfahren zur Charakterisierung und Identifizierung disseminierter und metastasierter Krebszellen
|
CA2303404A1
(en)
*
|
1997-09-11 |
1999-03-18 |
Abbott Laboratories |
Reagents and methods useful for detecting diseases of the prostate
|
US6300088B1
(en)
|
1997-11-24 |
2001-10-09 |
Duke University |
Method of detecting prostate specific antigen
|
US5972615A
(en)
|
1998-01-21 |
1999-10-26 |
Urocor, Inc. |
Biomarkers and targets for diagnosis, prognosis and management of prostate disease
|
US6673914B1
(en)
|
1998-01-22 |
2004-01-06 |
John Wayne Cancer Institute |
Human tumor-associated gene
|
CA2330628A1
(en)
|
1998-05-01 |
1999-11-11 |
Queen's University At Kingston |
Method for diagnosing a vascular condition
|
CA2328377A1
(en)
*
|
1998-05-21 |
1999-11-25 |
Diadexus Llc |
A novel method of diagnosing, monitoring, and staging prostate cancer
|
US6861215B1
(en)
*
|
1998-05-21 |
2005-03-01 |
Diadexus, Inc. |
Method of diagnosing, monitoring, and staging prostate cancer
|
EP1100903A1
(en)
*
|
1998-07-24 |
2001-05-23 |
THE UNITED STATES OF AMERICA, as represented by the Secretary of the Department of Health and Human Services |
Pb 39, a gene dysregulated in prostate cancer, and uses thereof
|
US7226731B1
(en)
|
1998-07-24 |
2007-06-05 |
The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services |
PB 39, a gene dysregulated in prostate cancer, and uses thereof
|
FR2782730B1
(fr)
*
|
1998-08-25 |
2002-05-17 |
Biocom Sa |
Procede de separation cellulaire pour l'isolation de cellules pathogeniques, notamment cancereuses rares, equipement et reactif pour la mise en oeuvre du procede et application du procede
|
US20080261292A1
(en)
*
|
1998-09-22 |
2008-10-23 |
Oncomedx, Inc. |
Method Enabling the Use of Extracellular Ribonucleic Acid (RNA) Extracted from Plasma or Serum to Detect, Monitor or Evaluate Cancer or Premalignant Conditions
|
US8163524B2
(en)
*
|
1998-09-22 |
2012-04-24 |
Oncomedx, Inc. |
Comparative analysis of extracellular RNA species
|
US20060204989A1
(en)
*
|
1998-09-22 |
2006-09-14 |
Kopreski Michael S |
Comparative analysis of extracellular RNA species
|
EP1151142A2
(en)
*
|
1999-01-28 |
2001-11-07 |
Gen-Probe Incorporated |
Nucleic acid sequences for detecting genetic markers for cancer in a biological sample
|
US6156515A
(en)
*
|
1999-02-09 |
2000-12-05 |
Urocor, Inc. |
Prostate-specific gene for diagnosis, prognosis and management of prostate cancer
|
US6875854B1
(en)
|
1999-11-18 |
2005-04-05 |
The Brigham And Women's Hospital, Inc. |
Compositions and methods for the improved diagnosis and treatment of germ cell tumors
|
ES2367280T3
(es)
*
|
2001-07-25 |
2011-11-02 |
Oncomedx Inc. |
Métodos para evaluar estados patológicos usando arn extracelular.
|
US20100159464A1
(en)
*
|
2001-11-05 |
2010-06-24 |
Oncomedx, Inc. |
Method for Detection of DNA Methyltransferase RNA in Plasma and Serum
|
US20030104454A1
(en)
*
|
2001-11-05 |
2003-06-05 |
Kopreski Michael S. |
Method for detection of DNA methyltransferase RNA in plasma and serum
|
CA2432365A1
(en)
*
|
2003-06-30 |
2004-12-30 |
Jack A. Schalken |
Specific method of prostate cancer detection based on pca3, and kits therefore
|
WO2007016548A2
(en)
*
|
2005-08-01 |
2007-02-08 |
The Ohio State University Research Foundation |
Micro-rna-based methods and compositions for the diagnosis, prognosis and treatment of breast cancer
|
CN103028120B
(zh)
*
|
2005-09-12 |
2015-08-12 |
俄亥俄州立大学研究基金会 |
用于诊断或治疗bcl2相关癌症的组合物和方法
|
CN101312740A
(zh)
*
|
2005-10-05 |
2008-11-26 |
俄亥俄州立大学研究基金会 |
Wwox基因、包含该基因的载体和在癌症治疗中的用途
|
EP2468890B1
(en)
|
2006-01-05 |
2014-03-19 |
The Ohio State University Research Foundation |
MicroRNA-based methods and compositions for the diagnosis and treatment of solid cancers of the breast or lung
|
ES2536438T3
(es)
|
2006-01-05 |
2015-05-25 |
The Ohio State University Research Foundation |
Métodos y composiciones basados en los microARN para el diagnóstico, pronóstico y tratamiento del cáncer de pulmón
|
EP2586454B1
(en)
|
2006-01-05 |
2014-10-08 |
The Ohio State University Research Foundation |
MicroRNA expressions abnormalities in pancreatic endocrine and acinar tumors
|
EP2369011A1
(en)
|
2006-03-20 |
2011-09-28 |
The Ohio State University Research Foundation |
Microrna fingerprints during human megakaryocytopoiesis
|
WO2008008430A2
(en)
*
|
2006-07-13 |
2008-01-17 |
The Ohio State University Research Foundation |
Micro-rna-based methods and compositions for the diagnosis and treatment of colon cancer-related diseases
|
CA2663027A1
(en)
*
|
2006-09-19 |
2008-08-14 |
The Ohio State University Research Foundation |
Tcl1 expression in chronic lymphocytic leukemia (cll) regulated by mir-29 and mir-181
|
AU2007314212B2
(en)
|
2006-11-01 |
2014-05-29 |
The Govt. Of The Usa As Represented By The Secretary Of The Department Of Health And Human Services |
MicroRNA expression signature for predicting survival and metastases in Hepatocellular carcinoma
|
EP2109687B1
(en)
*
|
2007-01-31 |
2014-06-04 |
The Ohio State University Research Foundation |
Micro-rna-based methods for the treatment of acute myeloid leukemia
|
AU2008248319B2
(en)
*
|
2007-04-30 |
2013-09-05 |
The Ohio State University Research Foundation |
Methods for differentiating pancreatic cancer from normal pancreatic function and/or chronic pancreatitis
|
CN101711287B
(zh)
*
|
2007-06-08 |
2016-04-27 |
由卫生与公众服务部代表的美利坚合众国政府 |
确定肝细胞癌亚型和检测肝癌干细胞的方法
|
EP2719773A3
(en)
*
|
2007-06-15 |
2014-07-30 |
The Ohio State University Research Foundation |
miRNA as marker for acute lamphomic leucemia
|
US8367632B2
(en)
*
|
2007-07-31 |
2013-02-05 |
Ohio State University Research Foundation |
Methods for reverting methylation by targeting methyltransferases
|
EP2650383A1
(en)
|
2007-08-03 |
2013-10-16 |
The Ohio State University Research Foundation |
Ultraconserved regions encoding ncRNAs
|
DE102007037008B4
(de)
*
|
2007-08-06 |
2015-09-10 |
Siemens Aktiengesellschaft |
Diagnosesubstanz zur Anwendung in einem Verfahren zur Bestimmung der Aggressivität eines Prostatatumors
|
WO2009026487A1
(en)
*
|
2007-08-22 |
2009-02-26 |
The Ohio State University Research Foundation |
Methods and compositions for inducing deregulation of epha7 and erk phosphorylation in human acute leukemias
|
EP2183393B1
(en)
*
|
2007-09-06 |
2014-06-11 |
The Ohio State University Research Foundation |
Microrna signatures in human ovarian cancer
|
US20090136942A1
(en)
*
|
2007-09-18 |
2009-05-28 |
Oncomedx, Inc. |
Analysis of Extracellular RNA
|
CN103937876B
(zh)
*
|
2007-10-11 |
2016-08-17 |
俄亥俄州立大学研究基金会 |
用于诊断和治疗食管腺癌的方法和组合物
|
CN103898069A
(zh)
|
2007-10-26 |
2014-07-02 |
俄亥俄州立大学研究基金会 |
鉴定脆性组氨酸三联体(Fhit)相互作用的方法及其用途
|
CA2707157A1
(en)
*
|
2007-11-30 |
2009-06-04 |
The Ohio State University Research Foundation |
Microrna expression profiling and targeting in peripheral blood in lung cancer
|
US20110054009A1
(en)
*
|
2008-02-28 |
2011-03-03 |
The Ohio State University Research Foundation |
MicroRNA-Based Methods and Compositions for the Diagnosis, Prognosis and Treatment of Prostate Related Disorders
|
JP2011517932A
(ja)
*
|
2008-02-28 |
2011-06-23 |
ジ・オハイオ・ステイト・ユニバーシティ・リサーチ・ファウンデイション |
ヒト慢性リンパ球性白血病(ccl)と関連するマイクロrnaシグネチャーおよびその使用
|
JP5745401B2
(ja)
|
2008-06-11 |
2015-07-08 |
アメリカ合衆国 |
肝細胞癌についての予測マーカーとしてのMiR−26ファミリーの使用および療法に対する反応性
|
US8916533B2
(en)
|
2009-11-23 |
2014-12-23 |
The Ohio State University |
Materials and methods useful for affecting tumor cell growth, migration and invasion
|
WO2012065049A1
(en)
|
2010-11-12 |
2012-05-18 |
The Ohio State University Research Foundation |
Materials and methods related to microrna-21, mismatch repair, and colorectal cancer
|
CN103313706A
(zh)
|
2010-11-15 |
2013-09-18 |
俄亥俄州立大学研究基金会 |
控制释放粘膜粘合系统
|
WO2012122239A1
(en)
|
2011-03-07 |
2012-09-13 |
The Ohio State University |
MUTATOR ACTIVITY INDUCED BY MICRORNA-155 (miR-155) LINKS INFLAMMATION AND CANCER
|
CN104364390B
(zh)
|
2011-10-14 |
2016-08-24 |
俄亥俄州立大学 |
与卵巢癌相关的方法和材料
|
EP2790735A4
(en)
|
2011-12-13 |
2015-12-09 |
Ohio State Innovation Foundation |
METHODS AND COMPOSITIONS RELATING TO MIR-21 AND MIR-29A, EXOSOME INHIBITION, AND CANCER METASTASIS
|
US8859202B2
(en)
|
2012-01-20 |
2014-10-14 |
The Ohio State University |
Breast cancer biomarker signatures for invasiveness and prognosis
|
CN111518170A
(zh)
*
|
2020-05-09 |
2020-08-11 |
新乡医学院 |
基于fret的psa荧光探针、制备方法及其应用
|